Cargando…

Evolution of national and European policies in the field of rare diseases and their impact over the past five years

Detalles Bibliográficos
Autores principales:	Rodwell, Charlotte, Aymé, Ségolène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249663/ http://dx.doi.org/10.1186/1750-1172-9-S1-P13

Ejemplares similares

The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community
por: Aymé, Ségolène, et al.
Publicado: (2014)

The European Union Committee of Experts on Rare Diseases (EUCERD): a new committee to help the European Commission advance in the field of rare disease policy
por: Moliner, Antoni Montserrat, et al.
Publicado: (2010)

Scope of centres of expertise for rare diseases in European countries where they exist
por: Rodwell, Charlotte, et al.
Publicado: (2012)

WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art
por: Aymé, Ségolène, et al.
Publicado: (2010)

Rare diseases research in Europe: an overview based on data from the Orphanet database
por: Martin, Natalia, et al.
Publicado: (2010)

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
por: Hivert, Virginie, et al.
Publicado: (2010)

Classification of rare diseases: a worldwide effort to contribute to the International Classification of Diseases
por: Rath, Ana, et al.
Publicado: (2010)

European Project for Rare Diseases National Plans Development (EUROPLAN)
por: Taruscio, Domenica, et al.
Publicado: (2010)

Genetic testing in Europe: transborder testing is a necessity
por: Jovanovic, Mariana, et al.
Publicado: (2010)

How to code rare diseases with international terminologies?
por: Rath, Ana, et al.
Publicado: (2014)

State of the art of services in Europe: where are the problems?
por: Aymé, Ségolène
Publicado: (2010)

Policy options to deal with high-cost medicines – survey with European policy-makers
por: Zimmermann, Nina, et al.
Publicado: (2015)

Five-hundred years of medicine gone to waste? Negotiating intercultural health policy in Ecuador
por: Llamas-Montoya, Ana, et al.
Publicado: (2014)

Evolution of a High-Risk Cancer Registry: past, present and future
por: Lewandowski, Michelle S, et al.
Publicado: (2010)

Five-year evolution of drug prescribing in a university adult intensive care unit
por: Voirol, P, et al.
Publicado: (2010)

State of the art of rare disease activities in Europe: a EUCERD perspective
por: Aymé, Ségolène
Publicado: (2012)

Chronic recurrent multifocal osteomyelitis: experience from a single pediatric rheumatology center over the past ten years
por: Pastore, Serena, et al.
Publicado: (2014)

The importance of review articles in making the voice of rare diseases heard: OJRD’s 10th anniversary
por: Aymé, Ségolène
Publicado: (2016)

Evolution of infant mortality in the Paris region over the past two decades
por: Matulonga Diakiese, B
Publicado: (2023)

P124: Increase in alcohol-based hand rub consumption over a period of five years in German hospitals
por: Behnke, M, et al.
Publicado: (2013)

Visiting policies in Italian pediatric ICUs: a national survey
por: Giannini, A, et al.
Publicado: (2008)

5610939 RARE ANAEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP)
por: Colombatti, R., et al.
Publicado: (2023)

Visiting policies in Italian intensive care units: a national survey
por: Giannini, A, et al.
Publicado: (2007)

Tetanus in the ICU: increasing incidence in the past 5 years
por: Casado, R, et al.
Publicado: (2006)

Prohibit WP2 – systematic review of national guidelines in European countries
por: Martin, M, et al.
Publicado: (2011)

Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding
por: Aymé, Ségolène, et al.
Publicado: (2015)

http://www.euro-wabb.org: an EU Register for Alstrom, Bardet Biedl and other rare syndromes
por: Barrett, T, et al.
Publicado: (2012)

Orphanet Journal of Rare Diseases: Launch Editorial
por: Aymé, Ségolène, et al.
Publicado: (2006)

Aeromedical evacuation of the French Army: survey of the past 10 years
por: Coste, S, et al.
Publicado: (2010)

Evaluation of population newborn screening practices for rare disorders in member states of the European Union
por: Vittozzi, Luciano, et al.
Publicado: (2010)

New e-health services for the European Network for Rare and Congenital Anaemias (e-ENERCA)
por: Vives Corrons, J L, et al.
Publicado: (2014)

HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs)
por: Jõgeda, Ene-Ly, et al.
Publicado: (2015)

P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
por: Sarazin, V, et al.
Publicado: (2009)

The Evolution of Medicine and Surgery for the past Thirty-five Years
por: Fly, A. W.
Publicado: (1910)

Key influences over actors’ preferences and use of evidence in policy development: insights from the Nigerian IMNCH strategy
por: Mbachu, Chinyere, et al.
Publicado: (2014)

An Objective Approach to Identify Priority Rare Diseases for the Development of Solutions Reducing the Diagnostic Delay Based on French Data
por: Chazal, Pierre Etienne, et al.
Publicado: (2021)

Interpretation of seizure evolution pathways via a mean-field cortical model
por: Dadok, Vera M, et al.
Publicado: (2012)

National rare diseases registry in Spain: pilot study of the Spanish Rare Diseases Registries Research Network (SpainRDR)
por: Alonso, Verónica, et al.
Publicado: (2014)

The impact of Ghana's National Health Insurance Scheme median pharmaceutical pricing methodology and reimbursement policy on the pharmaceutical system
por: Mordi, Dumebi O, et al.
Publicado: (2015)

Five years experience of critical care bereavement follow-up
por: Voisey, S, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_uhfl34o29f2g3nu7kiblqr5nso